Autophagy is a stress response protecting cells from unfavorable conditions, such as nutrient starvation. The class III phosphatidylinositol-3 kinase, Vps34, forms multiple complexes and regulates both intracellular vesicle trafficking and autophagy induction. Here, we show that AMPK plays a key role in regulating different Vps34 complexes. AMPK inhibits the nonautophagy Vps34 complex by phosphorylating T163/S165 in Vps34 and therefore suppresses overall PI(3)P production and protects cells from starvation. In parallel, AMPK activates the proautophagy Vps34 complex by phosphorylating S91/ S94 in Beclin1 to induce autophagy. Atg14L, an autophagy-essential gene present only in the proautophagy Vps34 complex, inhibits Vps34 phosphorylation but increases Beclin1 phosphorylation by AMPK. As such, Atg14L dictates the differential regulation (either inhibition or activation) of different Vps34 complexes in response to glucose starvation. Our study reveals an intricate molecular regulation of Vps34 complexes by AMPK in nutrient stress response and autophagy.
SUMMARY
Autophagy is a stress response protecting cells from unfavorable conditions, such as nutrient starvation. The class III phosphatidylinositol-3 kinase, Vps34, forms multiple complexes and regulates both intracellular vesicle trafficking and autophagy induction. Here, we show that AMPK plays a key role in regulating different Vps34 complexes. AMPK inhibits the nonautophagy Vps34 complex by phosphorylating T163/S165 in Vps34 and therefore suppresses overall PI(3)P production and protects cells from starvation. In parallel, AMPK activates the proautophagy Vps34 complex by phosphorylating S91/ S94 in Beclin1 to induce autophagy. Atg14L, an autophagy-essential gene present only in the proautophagy Vps34 complex, inhibits Vps34 phosphorylation but increases Beclin1 phosphorylation by AMPK. As such, Atg14L dictates the differential regulation (either inhibition or activation) of different Vps34 complexes in response to glucose starvation. Our study reveals an intricate molecular regulation of Vps34 complexes by AMPK in nutrient stress response and autophagy.
INTRODUCTION
Autophagy is a catabolic process that maintains cellular homeostasis in response to a wide spectrum of cellular stresses, such as nutrient starvation, infection, damaged organelles, and protein aggregates (Mizushima, 2007; Yang and Klionsky, 2010) . These processes are coordinated by ATG proteins; among them the ULK1 and Vps34 complexes are well known to function as important regulators in autophagy initiation and progression (Nakatogawa et al., 2009; Suzuki et al., 2007) .
Vps34 is a class III PI3K that phosphorylates the 3-position of phosphatidylinositol to produce phosphatidylinositol-(3)-phosphate (PI(3)P), which is a key membrane marker for both intracellular trafficking and autophagosome formation (Backer, 2008) . PI(3)P functions to recruit proteins with PI(3)P binding domains, such as FYVE or PX domain, to modulate membrane activity (Obara and Ohsumi, 2011) . Extensive yeast genetic and biochemical analyses have established that Vps34 forms multiple complexes that are responsible for its different cellular functions (Kametaka et al., 1998; Kihara et al., 2001; Obara et al., 2006) . The autophagy-specific Vps34 complex consists of Vps34, Vps15, Atg6/Vps30, and Atg14 (complex I). In parallel, Atg6/ Vps30 interacts with Vps38 to form the distinctive Vps34 complex II, which is required for endosome-to-Golgi retrograde trafficking.
The mammalian Vps34 also exists in different complexes and is involved in a variety of cellular functions, such as multivesicular body pathway, retrograde trafficking from endosomes to the Golgi, phagosome maturation, and autophagy (Backer, 2008) . Core components of the Vps34 complexes include Vps34 and p150 (Vps15). Beclin1, a mammalian homolog of Atg6, participates in Vps34 complex formation and recruits additional proteins, such as Atg14L/Barkor and UVRAG. Recent reports demonstrated that Atg14L and UVRAG devote the Vps34 complex to autophagy (Liang et al., 2006; Matsunaga et al., 2009; Sun et al., 2008) . In addition, VMP1 (Ropolo et al., 2007) , Ambra-1 (Fimia et al., 2007) , Bif-1 (Takahashi et al., 2007) , and Rubicon (Matsunaga et al., 2009) are also reported as components of the Vps34 complex, suggesting that many different Vps34 complexes are present and contribute to a wide range of cellular regulations.
The complexity of Vps34 biology indicates that multiple layers of regulation probably impinge on different complexes. Much effort in understanding Vps34 function has been centered on the interaction between Vps34 and Beclin1. The antiapoptotic protein Bcl-2 may inhibit autophagy by disrupting Vps34-Beclin1 interaction due to its competitive binding to Beclin1 (Pattingre et al., 2005) . JNK is suggested to phosphorylate Bcl-2 and dissociate its interaction from Beclin1 (Wei et al., 2008) . DAP-kinase and CDK1/5 are also reported to regulate Vps34-Beclin1 interaction through phosphorylation (Furuya et al., 2010; Zalckvar et al., 2009) . Although the Vps34 complex has long been believed to have a critical role in autophagy, it is not even clear whether Vps34 lipid kinase is activated upon the autophagy-inducing conditions. Also, it remains to be determined how the lipid kinase activity of different Vps34 complexes is regulated and whether there is coordination of these different Vps34 complexes under starvation.
AMPK is a key cellular energy sensor and functions to maintain energy homeostasis upon nutrient starvation (Hardie, 2007) . Lines of evidence support a role of AMPK in autophagy induction, including ULK1 activation, in response to nutrient starvation (Egan et al., 2011; Kim et al., 2011) . In this study, we show a molecular mechanism underlying differential regulations of pro-and nonautophagy Vps34 complexes by AMPK in nutrient stress and autophagy. These intricate regulations are accomplished by a direct phosphorylation of Vps34 T163/S165 and Beclin1 S91/S94 by AMPK under the control of autophagyspecific subunits, such as Atg14L.
RESULTS

Activity of Different Vps34 Complexes Is Differentially Regulated by Glucose Starvation
To study the regulation of different Vps34 complexes upon autophagy induction, we first measured the lipid kinase activity of four different Vps34 complex pools from glucose-starved cells. Four different Vps34 complexes were prepared by immunoprecipitation (IP) against Vps34, Beclin1, Atg14L, and UVRAG, respectively. Glucose starvation decreased the lipid kinase activity of IP isolated with antibody against Vps34 or Beclin1, whereas the lipid kinase activity of IP isolated with antibody against either Atg14L or UVRAG was increased by glucose starvation ( Figure 1A) . Notably, the basal Vps34 lipid kinase activity in the Atg14L-and UVRAG-IP was much higher than that of the Vps34-or Beclin1-IP. We performed western blotting to determine the composition of the above IPs. When normalized to Vps34 protein levels, we found that Vps34-IP contained p150 (Vps15) and some Beclin1 but no detectable level of Atg14L or UVRAG ( Figure 1B) . The Beclin1-IP contained Vps34, p150, and some Atg14L, but little UVRAG. The Atg14L and UVRAG-IPs contained Vps34, p150, Beclin1, and Atg14L or UVRAG in a mutually exclusive manner, as previously reported (Itakura et al., 2008) . Notably, glucose starvation had almost no effect on Vps34 protein levels in each IP ( Figure 1A) , indicating that the starvation-induced changes in Vps34 activity were not due to alteration of the composition of each Vps34 complex. Similar IP analyses in different cell lines suggest that the stoichiometry of the Vps34 complex varies in the cell lines. For example, the majority of Vps34 exists as an Atg14L-free complex in MEFs and NIH 3T3, but a significant amount of Atg14L was observed in Vps34-IP from HeLa cells, possibly due to different expression levels of Beclin1 and Atg14L ( Figure S1A ).
To further explore the relative abundance of different Vps34 complexes in MEFs, we performed quantitative immunodepletion with increasing amounts of antibodies ( Figure 1C ). Quantitative removal of Vps34 resulted in an effective depletion of p150, Beclin1, and Atg14L and a significant decrease of UVRAG, indicating that most of Beclin1 and Atg14L are associated with Vps34. Quantitative removal of Beclin1 fully depleted Atg14L but a significant amount of Vps34 and p150 still remained in the post-IP supernatant, suggesting the existence of a large amount of Beclin1-free Vps34 complex in MEFs. Importantly, Atg14L immunodepletion did not effectively reduce Vps34 or Beclin1, indicating that the majority of Vps34 or Beclin1 is not associated with Atg14L. Immunodepletion of Atg14L or UVRAG did not affect the levels of UVRAG or Atg14L, respectively, confirming a mutually exclusive association of Atg14L and UVRAG with the Vps34 complex. The above data demonstrate the existence of four distinct Vps34 complexes and their relative abundance in MEFs.
The reduction in lipid kinase activity from Beclin1-IP is quite perplexing because it also contains Atg14L, although at a much reduced level. To further investigate the differential regulation of different Vps34 complexes, we attempted to obtain a highly enriched individual Vps34 population as outlined in Figure S1B. For simplicity, we named them Vps34-containing PI3K-III Complex 1 (VIC1), labeled as Vps34, VIC2 (Beclin1), VIC3 (Atg14L), and VIC4 (UVRAG). The compositions of these four complexes were confirmed by western blots. As shown in Figure 1D , purification and fractionation successfully provided an individual Vps34 complex, as anticipated. Consistent with Figure 1A , the lipid kinase assay clearly showed that VIC3 and VIC4 were activated, but VIC1 and VIC2 were inhibited by glucose starvation ( Figure 1E ). The activities of VIC1 and VIC2 were low, but further decreased upon the starvation. Our data clearly demonstrate that different Vps34 complexes are differentially regulated in response to glucose starvation.
AMPK Is Required for Glucose-Starvation-Induced Vps34 Regulation As a primary energy source, glucose starvation results in cellular energy depletion and concomitantly activates AMPK, which is important for autophagy induction. Therefore, we tested whether AMPK is required for the regulation of Vps34 complexes in response to glucose starvation, in which AMPK was activated as evidenced by the increased phosphorylation of AMPK and its substrate, ACC ( Figure S1C ). In this experimental setting, we determined Vps34 lipid kinase activity in AMPKa wild-type (WT) and a1/a2 double-knockout (DKO) mouse embryonic fibroblasts (MEFs). Notably, the regulation of Vps34 complex activity by glucose starvation was blunted in AMPKa-DKO MEFs both for VIC1 and VIC2 inhibition and for VIC3 and VIC4 activation ( Figure 1F) .
To further confirm a role of AMPK in glucose-starvationinduced Vps34 regulation, we immunopurified the four different Vps34 complexes from HEK293 cells cotransfected with a kinase-inactive AMPKa (AMPK-DN). Expression of AMPK-DN diminished the effect of glucose starvation on Vps34 regulation ( Figure S1E ). Moreover, coexpression of WT AMPKa inhibited VIC1 and VIC2 but activated VIC3 and VIC4 even in the glucose-rich condition ( Figure S1F) . Notably, the nonautophagy Vps34 complexes VIC1 and VIC2 showed quite low lipid kinase activity when normalized with Vps34 protein compared with VIC3 and VIC4, which is consistent with the reports that Atg14L and UVRAG activate Vps34 activity (Liang et al., 2006; Zhong et al., 2009 ). Consistently, treatment with the AMPK activators 2-DG or Metformin was sufficient to enhance VIC3 activity and suppress VIC2 activity ( Figure S1G ). Collectively, these data demonstrate a critical role of AMPK in the differential regulation of proautophagy (VIC3 and VIC4) and nonautophagy (VIC1 and VIC2) Vps34 complexes in response to glucose starvation.
AMPK Directly Regulates Vps34 Complex Activity
We asked whether AMPK could directly regulate Vps34 complex activity. Four different endogenous Vps34 immune complexes were incubated with AMPK in vitro in the presence of cold ATP and then were subjected to Vps34 lipid kinase assay. Similar to glucose starvation, in vitro AMPK treatment strongly inhibited VIC1 and VIC2 but activated VIC3 and VIC4 (Figure 2A) . We also performed in vitro AMPK treatment on pure Vps34 populations prepared by the procedure outlined in Figure S1B and obtained the results ( Figure 2B ) similar to those shown in Figure 2A , suggesting that AMPK plays a direct role in Vps34 regulation.
To verify that AMPK regulates Vps34 by phosphorylation, we treated the Vps34 complex with both AMPK and lambda phosphatase (l PPase) as outlined in Figure S2A . We found that l PPase treatment reversed both the inhibitory effect of AMPK on VIC1 and VIC2 and the activating effect on VIC3 (Figure 2C ), indicating that AMPK regulates Vps34 complexes by phosphorylation. Consistently, AMPK could not activate VIC3 in the absence of ATP during in vitro treatment ( Figure S2B ). Next, we investigated whether phosphorylation by AMPK plays an important role in Vps34 regulation induced by glucose starvation ( Figure 2D ). Dephosphorylation by l PPase treatment activated VIC1 and VIC2 isolated from the glucose starvation condition to levels similar to those isolated from unstarved cells. Moreover, dephosphorylation inhibited the lipid kinase activity of VIC3 isolated from glucose starvation. These results demonstrate that phosphorylation is the major mechanism for Vps34 complex regulation by glucose starvation. Importantly, rephosphorylation of l PPase-treated Vps34 complexes by AMPK was sufficient to inhibit VIC1 and VIC2 and to activate VIC3 (Figure 2D ) to the level similar to the complexes from glucosestarved cells. A parallel experiment showed that l PPase or AMPK treatment affected the UVRAG-containing VIC4 in a manner similar to VIC3 regulation ( Figure S2C ). Collectively, these data demonstrate that AMPK-dependent phosphorylation is necessary and sufficient for Vps34 regulation (both inhibition of nonautophagy VIC1 and VIC2 and activation of proautophagy VIC3 and VIC4) in response to glucose starvation.
Atg14L Converts Vps34 Regulation from Inhibition to Activation by AMPK
The lipid kinase activities of VIC2 and VIC3 show opposite responses to glucose starvation as well as to AMPK treatment. Figure 1D were treated with AMPK in vitro and assayed for the lipid kinase assay (n = 3). (C) AMPK regulates the Vps34 complex via phosphorylation. The indicated Vps34 complexes were immunopurified from MEFs in a glucose-rich condition. The complexes were incubated with AMPK and l PPase as indicated by arrows for order of the treatment (n = 3). (D) AMPK-mediated phosphorylation is necessary and sufficient for the regulation of Vps34 complexes by glucose starvation. The Vps34 complexes were immunopurified from glucose-starved MEFs and then treated with AMPK and l PPase (n = 3). (E) Atg14L converts the Vps34-Beclin1 complex from inhibition to activation by AMPK. Vps34-Beclin1 complex was immunopurified from U2OS cells, to which purified Atg14L-Flag/6His protein was added. Also, Atg14L-containing Vps34 complex was directly prepared by Atg14L-IP from the cells as a control. The immune complex was treated with AMPK in vitro and assayed for Vps34 lipid kinase assay (n = 2). (F) Overexpression of Atg14L activates Vps34 kinase activity of Beclin1-IP in response to AMPK treatment. Vps34 complexes were immunopurified from the U2OS cell lines overexpressing Atg14L, which was induced by DOX, and then incubated with AMPK in vitro before the lipid kinase assay, as indicated (n = 2). Data are represented as mean ± S.D. See also Figure S2 .
A key difference between VIC2 and VIC3 is the presence of the autophagy-specific subunit Atg14L in VIC3. We hypothesized that Atg14L may play a critical role in switching Vps34 regulation from inhibition to activation by AMPK. To test this possibility, we added purified Atg14L into the endogenous Beclin1-IP (VIC2). In vitro addition of Atg14L to VIC2 increased the basal activity in a dose-dependent manner ( Figure S2D ). The purified Atg14L protein had no contaminating Vps34 activity ( Figure S2E ). Importantly, addition of Atg14L switched VIC2 regulation by AMPK from inhibition to activation ( Figure 2E ). Therefore, Atg14L is a key factor for determining the effect (either inhibition or activation) of AMPK on Vps34 complexes. Experiments using several Atg14L deletion mutants further demonstrated that the N-terminal 72 residues and the C-terminal BATS domain of Atg14L are dispensable for Vps34 activation by AMPK ( Figure S2F ).
One possible explanation for AMPK-induced inhibition of Beclin1-IP is that only a very small fraction of Beclin1-IP contains Atg14L (Figures 1B and 1C) . Therefore, inhibition of the Atg14L-free complex (VIC2) by AMPK overwhelmed the activating effects of the very small fraction of Atg14L-contacting complex (VIC3) in the Beclin-IP. If so, we reasoned that overexpression of Atg14L should increase the fraction of endogenous Beclin1 in complex with Atg14L. As predicted, Beclin1-IP from the Atg14L-overexpressing cells contained a higher level of the ectopic Atg14L protein, which was comparable to endogenous Atg14L in VIC3 when normalized to the Vps34 protein level (Figure 2F) . As a consequence of increased Atg14L, the lipid kinase activity of Beclin1-IP prepared from Atg14L-overexpressing cells was indeed activated by AMPK. Collectively, these data demonstrate that Atg14L plays a key role in determining whether the Vps34 complex is inhibited (in the absence of Atg14L) or activated (in the presence of Atg14L) by AMPK.
AMPK Phosphorylates Vps34 and Beclin1
It is intriguing how AMPK exerts opposite effect on different Vps34 complexes that have the same catalytic subunit. Considering that AMPK regulates the Vps34 complex by phosphorylation, we performed in vitro AMPK phosphorylation of individual Vps34 complex subunits. We observed that Vps34 and Beclin1 were directly phosphorylated by AMPK in vitro ( Figures 3A and  S3A ). Based on mass spectrometry, systemic deletions, and site-directed mutation, we identified S91 and S94 in Beclin1 ( Figures S3B and S3C ) and T163 and S165 in Vps34 ( Figures  S3D and S3E) as the major AMPK phosphorylation sites. Notably, the Beclin1 phosphorylation sites do not fit the conventional AMPK consensus motif (Gwinn et al., 2008) . However, they align with two AMPK phosphorylation sites (S317 and S777) in ULK1 ( Figure 3B ) (Kim et al., 2011) . Also, the AMPK site S79 in ACC1 fits this sequence defined as Bas-Hyd-X-S-X-X-pS/ T-X-X-X-Hyd (Bas and Hyd denote for basic and hydrophobic residues, respectively). This may represent a new AMPK phosphorylation consensus sequence.
To confirm Vps34 and Beclin1 phosphorylations in vivo, we generated phosphospecific antibodies for Beclin1 and Vps34 and confirmed that the antibodies preferentially recognized the in vitro phosphorylated GST-Beclin1 and GST-Vps34 by AMPK ( Figure S3F ). Using these phosphospecific antibodies, we observed that glucose starvation increased the phosphorylation of endogenous Beclin1 S91/S94 and Vps34 T163/S165 (Figure 3C) . Importantly, these phosphorylations were abolished in AMPKa DKO MEFs, demonstrating that AMPK is required for Beclin1 and Vps34 phosphorylation. Consistently, the AMPK activators 2-DG and Metformin also increased phosphorylation of Vps34 and Beclin1 even in glucose-rich conditions, whereas an AMPK inhibitor, compound C, blocked glucose-starvationinduced phosphorylations ( Figure 3D) . Moreover, the coexpression of WT AMPKa, but not the kinase inactive mutant, induced phosphorylation of Beclin1 ( Figure S3G ) and Vps34 ( Figure S3H ) even in glucose-rich conditions. These data establish a physiological role for AMPK in the phosphorylation of Beclin1 S91/ S94 and Vps34 T163/S165 in response to glucose starvation.
Beclin1 Phosphorylation Is Required for Activation of the Proautophagy Vps34 Complex
Next, we wished to determine the function of phosphorylation in the regulation of Vps34 complexes. WT or phosphorylationdefective mutants (SA, denoting mutants of serine substitution by alanine) were coexpressed with Atg14L, and the Atg14L-associated complex (VIC3) was immunoprecipitated to determine Vps34 lipid kinase activity. We found that VIC3 containing the Beclin1 S91/94A (SA) could not be activated by glucose starvation or AMPK coexpression in vivo ( Figure 4A ), whereas the complex containing Beclin1 WT was activated by both conditions. This result suggests that phosphorylation of Beclin1 S91/ S94 is required for activation of the proautophagic Vps34 complex VIC3 by AMPK or glucose starvation. Consistently, the complex containing a phosphorylation-mimetic mutant of Beclin1 S91/94D (SD, denoting mutation of S91 and S94 by aspartate) showed higher basal activity even in glucose-rich conditions. In contrast, Vps34 phosphorylation was not required for VIC3 activation as demonstrated by the fact that the Vps34 T163/165A (SA)-containing VIC3 was similarly activated upon either glucose starvation or AMPK cotransfection despite having a higher basal activity ( Figure 4A ).
To further characterize the role of AMPK-induced phosphorylation in the Vps34 complex regulation, we prepared VIC1, VIC2, and VIC3 from the transfected cells and incubated them with AMPK in vitro ( Figure 4B ). Consistent with the in vivo data in Figure 4A , Beclin1 phosphorylation, but not Vps34 phosphorylation, was required for VIC3 activation by AMPK in vitro. Interestingly, Vps34 phosphorylation, but not Beclin1 phosphorylation, was required for inhibition of the nonautophagy VIC1 and VIC2 by AMPK in vitro ( Figure 4B ). These data indicate that the phosphorylation of Beclin1 and Vps34 protein play differential roles in the regulation of different Vps34 complexes by AMPK.
Atg14L appears to play a critical role in determining the effect, either activation or inhibition, of AMPK on Vps34 complex regulation. To test this possibility, we immunoprecipitated Vps34 complexes from the transfected cells, in which purified Atg14L was added to reconstitute the Atg14L-containing Vps34 complex ( Figure 4C ). Vps34 without Beclin1 (VIC1) was inhibited by AMPK and the addition of Atg14L did not affect this inhibition ( Figure 4C ). This is an expected result because Atg14L participates in the Vps34 complex via interaction with Beclin1. AMPK suppressed Vps34-Beclin1 complex (VIC2) activity, but in vitro Atg14L reconstitution reversed the effect of AMPK from inhibition to activation as shown in Figure 2E . However, the Atg14L-reconstituted Vps34 complex containing Beclin1 S91/ 94A was not activated by AMPK, demonstrating that Beclin1 phosphorylation activates the proautophagy Vps34 complex (VIC3) by AMPK.
Next, we questioned whether the association of Atg14L in the Vps34 complex is a prerequisite for activation by AMPK. When the Vps34-Beclin1 complex was first incubated with AMPK, followed by the addition of Atg14L, AMPK pretreatment did not activate Vps34 lipid kinase activity ( Figure 4C ), indicating that Atg14L must be present in the Vps34 complex in order for AMPK to activate the complex. Notably, AMPK treatment did not induce any change in the interaction between Beclin1 and Atg14L ( Figure 4C bottom panel) . Together, our data demonstrate that AMPK inhibits VIC2 via Vps34 phosphorylation and activates VIC3 via Beclin1 phosphorylation. Moreover, preassembly of Atg14L on the Vps34 complex is required for VIC3 activation by AMPK, suggesting that binding of Atg14L may affect phosphorylation of Vps34 and/or Beclin1 by AMPK.
Atg14L Enhances the Activating Phosphorylation of Beclin1 and Suppresses the Inhibitory Phosphorylation of Vps34 by AMPK We investigated the mechanism underlying Beclin1 and Vps34 differential phosphorylation in VIC2 and VIC3 despite the presence of both proteins in these complexes. To address this question, we determined the phosphorylation status of endogenous Vps34 and Beclin1 in VIC2 and VIC3. Interestingly, we found that the phosphorylation level of Beclin1 S91/S94 was significantly higher in VIC3 (Atg14L-IP) than that in VIC2 (Beclin1-IP) and the opposite was observed for Vps34 T163/S165 phosphorylation ( Figure 5A ). Phosphorylation of Vps34 was low in VIC3 and unaffected by glucose starvation, whereas phosphorylation of Vps34 in VIC2 was high and robustly induced. In line with endogenous data, ectopic expression of Atg14L strongly promoted Beclin1 phosphorylation ( Figure S4A ) and inhibited Vps34 phosphorylation ( Figure S4B ) upon AMPK coexpression. The above data demonstrate that in the absence of Atg14L, Vps34, but not Beclin1, is preferentially phosphorylated by AMPK. In contrast, when Atg14L is in the complex, Beclin1 is preferentially phosphorylated by AMPK. The majority of endogenous Beclin1 is not associated with Atg14L because Atg14L is limiting (Figures 1B-1D) . Therefore, we reasoned that increased Atg14L expression should enhance Beclin1 phosphorylation by AMPK in vivo because more Beclin1 would be in complex with Atg14L. When Atg14L was overexpressed, glucose starvation induced a much stronger phosphorylation in Beclin1 ( Figure 5B ). It should be noted that endogenous Beclin1 protein level was slightly increased upon Atg14L overexpression. Two mechanisms may explain these observations: Atg14L makes Beclin1 a better substrate for AMPK or a poorer substrate for a phosphatase. To this end, we determined the effect of Atg14L on Beclin1 phosphorylation by AMPK in vitro. Vps34-Beclin1 complex, VIC2, was immunopurified from the transfected cells, to which purified Atg14L was added to reconstitute VIC3 in vitro, and then both complexes were phosphorylated by AMPK to examine Beclin1 phosphorylation ( Figure 5C ). Atg14L dramatically increased the rate and degree of Beclin1 phosphorylation by AMPK. Similarly, Beclin1 was more potently phosphorylated by AMPK in VIC3 than VIC2 obtained from transfected cells coexpressing Atg14L ( Figure S4C ). These data support a model in which Atg14L makes Beclin1 a better substrate for phosphorylation by AMPK.
To determine the stoichiometry of endogenous Vps34 and Beclin1 phosphorylation, we phosphorylated Vps34 and Beclin1 in vitro under maximum AMPK phosphorylation condition, which possibly resulted in complete phosphorylation of Vps34 on T163/S165 and Beclin1 on S91/S94. Comparing the relative phosphorylation of endogenous Vps34 in VIC1 with the in vitro phosphorylated Vps34, we estimated that approximately 47.2% of endogenous Vps34 is phosphorylated in VIC1 under glucose starvation ( Figure 5D ). Similar experiments with Beclin1 showed that approximately 43.8% of Beclin1 was phosphorylated in VIC3 under glucose starvation ( Figure 5E ). As expected, AMPK phosphorylated Vps34 more efficiently in VIC1 than VIC3, whereas it phosphorylated Beclin1 more efficiently in VIC3 than VIC1. These data indicate that a substantial fraction of Vps34 and Beclin1 in specific Vps34 complexes can be phosphorylated upon glucose starvation. 
Beclin1 Phosphorylation Is Required for Autophagy Induction
To determine the biological function of Beclin1 phosphorylation by AMPK, we introduced Beclin1-WT and S91/94A mutant (SA) into the Beclin1 knockdown (Beclin1 KD) MEFs ( Figure 6A ). It is worth noting that the knockdown of endogenous Beclin1 was more efficient in ectopic Beclin1-expressing cells. Consistent with a critical role of Beclin1 in autophagy, glucose starvation could not induce autophagy in Beclin1 KD MEFs, as evidenced by LC3-II accumulation ( Figures 6B and S5A) . Re-expression of WT Beclin1 (Beclin1 KD/WT) rescued autophagy defects of Beclin1 KD MEFs, as indicated by LC3 lipidation (Figure 6B ), p62 degradation ( Figure S5B ), LC3-positive puncta formation ( Figure 6C) , and autophagosome/autolysosome-like vacuole formation ( Figure 6D ). Importantly, all autophagic markers were significantly compromised in Beclin1 KD MEFs expressing Beclin1 S91/94A (Beclin1 KD/SA), indicating the functional importance of Beclin1 S91/94 phosphorylation in autophagy in response to glucose starvation.
Notably, PI(3)P staining, using GST-2xFYVE as a probe, showed that overall PI(3)P level was decreased upon glucose starvation ( Figure 6C , middle, a quantitative ELISA analysis in (C) Beclin1 S91/S94A mutant is defective in autophagosome formation. The indicated MEFs were starved for glucose for 3 hr and the number of LC3 puncta was measured by endogenous LC3 staining (top). Also, PI(3)P level was determined by counting the spots of immunostaining using GST-2xFYVE protein as a probe (middle). The number of LC3 and PI(3)P double-positive puncta was counted by the overlap of LC3 and GST-2xFYVE staining and the percentage was shown (bottom). Ten to fifteen randomly selected images of the cells, n = 3 are shown. See Figure S5C for confocal images. (D) Beclin1 S91/84A mutant is defective in autophagy vacuole formation. The indicated MEFs were starved for glucose for 3 hr and the autophagy vacuoles were examined on electron microscopy (EM). The numbers of autophagosome/autolysosome-like structures (AV) from 15-20 randomly selected cells were counted (see the representative images in Figures S5D and S6C) . (E) Phosphorylation of Beclin1 S91/S94 is specifically involved in glucose-starvation-induced autophagy. The indicated Beclin1-MEFs were incubated with either a glucose-free or a 50 nM rapamycin-containing culture medium for 3 hr. Autophagy flux was examined in the presence of 10 mM NH 4 Cl. Data are represented as mean ± S.D. See also Figure S5 . Figure 7D ), which is consistent with the previous reports (Gulati et al., 2008) and our in vitro Vps34 kinase assay showing that the major Vps34 complexes VIC1 and VIC2 in MEFs were inhibited by glucose starvation. However, PI(3)P that colocalized with LC3 puncta, which were likely generated by proautophagy Vps34 complexes, was increased upon starvation ( Figure 6C , bottom). To directly monitor autophagy-relevant PI(3)P, we examined the localization of DFCP1 (an endoplasmic reticulum (ER)-associated FYVE domain-containing protein that translocates to initiate autophagosome structure and omegasomes during the starvation condition) using MEFs stably expressing GFP-DFCP1. Consistently, GFP-DFCP1 puncta were increased in response to glucose starvation, whereas overall GST-2xFYVE staining was decreased ( Figure S5E ), indicating that the autophagy-relevant PI(3)P is specifically increased upon starvation. These results are consistent with our observation that only proautophagic Vps34 complexes, such as Atg14L-containing VIC3, are activated upon the starvation.
To examine whether Beclin1 S91/S94 phosphorylation is specifically involved in AMPK-dependent autophagy induction, we examined the effect of rapamycin, an mTORC1 inhibitor, on LC3-II accumulation. As shown in Figure 6E , both glucose starvation (AMPK-dependent) and rapamycin treatment (mTORC1-dependent) induced LC3-II accumulation in Beclin1-WT-rescued MEFs. However, rapamycin could still induce autophagy in the Beclin1 S91/94A rescued cells, whereas glucose starvation did not induce LC3-II accumulation. These data indicate that Beclin1 S91/S94 phosphorylation is particularly important for glucose starvation and AMPK-dependent autophagy.
Vsp34 Phosphorylation Is Required for Cell Survival but Not for Autophagy in Response to Starvation
To determine the biological function of Vps34 phosphorylation by AMPK, we introduced Vps34 WT and T163/165A mutant (SA) into the Vps34 knockdown (Vps34-KD) MEFs. Although Vps34 knockdown was not as efficient as Beclin1 KD (Figure 7A) , it was sufficient to decrease autophagy ( Figure S5A ). Expression of either WT or T163/165A mutant rescued autophagy defects in Vps34-KD MEFs, as measured by LC3-II accumulation ( Figure 7B ), p62 degradation ( Figure S6A ), LC3-positive autophagosome formation ( Figure 7C) , and autophagosome/autolysosome-like structure formation ( Figure 6D ). These results are consistent with our Vps34 lipid kinase assays, in which Vps34 T163/165A mutant did not affect activation of the proautophagy Vps34 complex by glucose starvation (Figures 4A and 4B ). Our data indicate that phosphorylation of Vps34 by AMPK is not directly involved in autophagy regulation.
Although not required for autophagy induction, Vps34 phosphorylation by AMPK did play a role in overall PI(3)P production as determined by immunostaining with GST-2xFYVE ( Figure 7C ). We found that upon starvation, PI(3)P levels decreased in control cells or Vps34 WT reconstituted cells but did not decrease in the Vps34 SA mutant reconstituted MEFs. Quantitative PI(3)P ELISA assays confirmed that total cellular PI(3)P level was decreased by glucose starvation in the WT cells ( Figure 7D ). As expected, knockdown of Beclin1 or Vps34 reduced basal PI(3)P and abolished the glucose effect on PI(3)P. Re-expression of either WT Beclin1 or SA mutant restored the glucose-induced regulation of PI(3)P, indicating that Beclin1 phosphorylation is not required for the decrease of total PI(3)P by glucose starvation. In contrast, expression of the phosphorylation mutant Vps34 T163/165A could not restore PI(3)P regulation by glucose starvation (Figures 7C and 7D) . These experiments support an important role of Vps34 phosphorylation in the inhibition of nonautophagy Vps34 complexes and the decrease of total cellular PI(3)P production in response to glucose starvation.
We next tested whether inhibition of nonautophagy Vps34 plays a role in stress response by measuring cell survival under glucose starvation. Knockdown of either Beclin1 or Vps34 significantly decreased cell viability ( Figure 7E and Figure S6D ) upon glucose starvation, consistent with a protective role of autophagy in nutrient starvation. Beclin1 S91/94A-reconstituted cells were sensitive to glucose starvation, similar to Beclin1 KD MEFs. Notably, re-expression of Vps34 T163/165A could not rescue cell death in Vps34-KD cells, even though it rescued the autophagy defects. Therefore, our data suggest that AMPK-induced phosphorylation inhibits the nonautophagy Vps34 complexes to protect cells from starvation. These observations support an important role of inhibition of nonautophagy Vps34 complexes mediated by AMPK-dependent Vps34 T163/S165 phosphorylation in cellular starvation response. It is conceivable that some cellular activity, such as general vesicle trafficking, should be suppressed upon starvation to preserve energy for survival.
DISCUSSION
Multiple Vps34 complexes are reported to control distinct cellular processes, such as intracellular vesicle trafficking and autophagy (Backer, 2008; Obara and Ohsumi, 2011; Vergne and Deretic, 2010) . However, the regulation and coordination of various Vps34 complexes in response to changing cellular conditions remain largely unknown. In this study, we provide a molecular mechanism underlying a dynamic regulation of different Vps34 complexes in response to cellular energy depletion via the action of AMPK.
AMPK-Mediated Differential Regulation of Vps34
Complexes Although PI(3)P, a product of Vps34, is believed to recruit autophagy components on the autophagosome membrane, several studies have documented that Vps34 activity is inhibited and PI(3)P level is reduced upon starvation Gulati et al., 2008; Nobukuni et al., 2005) . Our study has provided a mechanistic interpretation for these paradoxical observations. We have prepared four different Vps34 complexes by immunoprecipitation against characteristic Vps34 complex subunits or by fractionation of highly enriched individual Vps34 complexes (VIC1-VIC4). Within the linear Vps34 lipid kinase assay condition ( Figure S7A ), we show that Vps34 complexes that are free of autophagy-specific subunits, Atg14L and UVRAG, are inhibited by glucose starvation. This is accomplished by the inhibitory phosphorylation of Vps34 T163/S165 by AMPK. In contrast, the proautophagy Vps34-containing Atg14L is activated via phosphorylation of Beclin1 S91/S94 by AMPK.
Both inhibitory and activating effects of glucose starvation on non-and proautophagy Vps34 complexes were blunted in AMPK-DKO MEFs, clearly demonstrating the role of AMPK in these regulations. We may consider the complication that the autophagy defect in AMPK-DKO MEFs is due to the metabolic changes caused by the loss of AMPK, which results in a decrease of glucose usage and lactate formation at 24 hr (Figure S7B) . However, these differences should not affect our analysis because cells were harvested at 3 hr. Moreover, the AMPK phosphorylation-defective Vps34 (or Beclin1) mutant was no longer regulated by the starvation, similar to the Vps34 complex in AMPK-DKO MEFs, indicating that the Vps34 regulation observed in our study is directly linked to AMPK activity.
Notably, most of Vps34 is not in complex with Atg14L or UVRAG, suggesting that the majority of Vps34 is in nonautophagy complexes, particularly in MEFs. In agreement with the analyses of Vps34 complex subunit proteins by immunoprecipitations, Atg14L and UVRAG were hardly detected in the Vps34 preparation by streptavidin pull-down ( Figure S7C ) and its lipid kinase activity was also inhibited by glucose starvation ( Figure  S7D ). Similarly, Beclin1-containing complexes were prepared by either streptavidin pull-down or anti-Beclin1 immunoprecipitation. Vps34 kinase activity of both Beclin1 preparations was similarly inhibited by glucose starvation ( Figure S7E ). These data demonstrate that results from the nonautophagy Vps34 complexes (Vps34-IP and Beclin-IP) in this study were not due to an artifact in the kinase assay caused by antibodies.
Autophagy can be induced by multiple stresses via different signaling mechanisms. Several kinases, such as JNK, DAPK, and CDK1/5, have been demonstrated to regulate Vps34 complexes by modulating the Vps34-Beclin1 interaction in response to stresses including nutrient starvation (Furuya (D) Vps34 phosphorylation is required for PI(3)P reduction in response to glucose starvation. The PI(3)P level in glucose-starved MEFs was determined by quantitative PI(3)P ELISA assay. The PI(3)P level was normalized by the amount of proteins used in the assay (n = 6; *p < 0.05; **p < 0.01). (E) Vps34 phosphorylation is required for cell survival in response to glucose starvation. Beclin1 or Vps34-MEF cells were starved for glucose for 24 hr and then the viability was measured by FACS analysis using AnexinV and propidium iodide (PI) double-staining (n = 4; **p < 0.01). (F) A schematic model of Vps34 regulation by AMPK in response to energy starvation. Data are represented as mean ± S.D. See also Figure S6 . Wei et al., 2008; Zalckvar et al., 2009 ). However, we did not observe any significant change in the interaction between Vps34 and Beclin1 upon glucose starvation, consistent with a previous report . It was recently reported that CCCP, a mitochondrial uncoupler that activates AMPK, induces autophagy in a manner dependent on mTORC1, but not AMPK (Kwon et al., 2011) . This suggests that mammalian autophagy is controlled by multiple layers of regulation, in which AMPK and mTORC1 may function cooperatively (for example, for ULK1 regulation) or differently (such as CCCP), depending on the stress. In the case of nutrient starvation, we observed that amino acid starvation, which relies on mTORC1 to activate autophagy, also differentially regulates Vps34 complexes in comparison to glucose starvation (data not shown). Therefore, the activation of autophagy-specific Vps34 complexes and the inhibition of the nonautophagy complex seem to be a common mechanism in autophagy in response to nutrient starvation. However, phosphorylation of Beclin1 S91/S94 is selectively required for glucose starvation and AMPK-dependent, but not rapamycin-induced, autophagy ( Figure 6E ).
Atg14L Determines Whether a Vps34 Complex Is Activated by AMPK
The autophagy-specific subunit Atg14L targets the Vps34 complex to the ER for autophagy (Matsunaga et al., 2010) . Our study reveals another critical role of Atg14L: to function as a switch that converts the inhibitory effect of AMPK (or glucose starvation) on Vps34 complex to an activation effect. Atg14L functions not only to prevent the inhibitory phosphorylation in Vps34, but also to promote the activating phosphorylation in Beclin1 by AMPK. As a result, we found that ectopic expression of Atg14L increased Beclin1 phosphorylation ( Figure 5B) as well as autophagy level ( Figure S7F ), possibly due to the increase of proautophagy VIC3 population. We speculate that Atg14L binding may induce conformational changes in the Vps34 complex to interfere with the availability of T163/S165 in Vps34 and promote the availability of S91/S94 in Beclin1 for phosphorylation by AMPK. We also found that another proautophagy Vps34 complex containing UVRAG is regulated by AMPKdependent phosphorylation as an Atg14L-containing complex ( Figure S2C ). UVRAG may act in a manner similar to Atg14L in Vps34 regulation. Indeed, UVRAG has been proposed to induce Beclin1 conformational changes, thus activating the Vps34 complex (Noble et al., 2008) . However, the overexpression of UVRAG could not rescue the loss of Atg14L in autophagy induction in response to glucose starvation ( Figure S7G ), which may support the current understanding that Atg14L and UVRAG function in initiation and maturation of autophagy, respectively.
Biology of Differential Regulation of Vps34 Complexes
We showed that glucose starvation decreases overall PI(3)P levels, but the pool of autophagy-related PI(3)P is increased, indicating that there are discrete functions for the different PI(3)P pools produced by different Vps34 complexes in cellular adaptation to stress. Local activation of the proautophagy Vps34 complex labels the membrane with PI(3)P for initiation and growth of autophagosome membrane, where LC3 protein is localized. Supporting a role of the local PI(3)P in autophagy, LC3/GFP-2xFYVE double-positive puncta are not increased by starvation in Beclin1 S91/94A-reconstituted MEFs, which are defective in autophagy induction. The decrease in total PI(3)P levels appears to be a consequence of the inhibition of the nonautophagy Vps34 complexes because cells expressing the nonphosphorylatable Vps34 T163/165A mutant could not decrease PI(3)P in response to starvation. Therefore, distinct Vps34 complexes appear to be responsible for production of different cellular pools of PI(3)P. Our data also show that the regulation of nonautophagy Vps34 complexes by AMPK is also important for stress response, as cells expressing the Vps34 T163/165A mutant are sensitive to starvation although autophagy remains normal. Knockdown of Vps34 in MEF did not show significant defects in endocytosis and trafficking, such as EGFR degradation, or in Cathepsin D processing, but resulted in dramatic retardation of cell growth and proliferation (data not shown), similar to a previous study of U-251 glioblastoma (Johnson et al., 2006) . We observe that the defect in cell proliferation is significantly restored by expression of either the WT or the phosphorylation mutant Vps34 (data not shown). One may speculate that a decrease of nonautophagy PI(3)P reduces cellular activities associated with cell growth and proliferation to maintain cell viability upon starvation. In fact, accumulating evidence supports the function of Vps34 in the cell cycle, growth, and cytokinesis (Furuya et al., 2010; Gulati et al., 2008; Sagona et al., 2010) . Therefore, inhibition of nonautophagy Vps34 represents an important, although little understood, aspect of the cellular stress response. In this study, we have not tested different localizations of these different Vps34 complexes in cells due to the lack of antibodies suitable for immunostaining. GFP-fusion proteins have been widely used to examine the localization of the Vps34 complex. However, we should consider the possibility of its artifact due to the expression levels of the target proteins. In particular, the stoichiometry of distinct Vps34 is very sensitive to the Vps34 complex protein level. For example, we found that Beclin1 phosphorylation was increased upon ectopic Atg14L expression ( Figure 5B ), indicating that the VIC3 subpopulation is increased. Therefore, we were not comfortable presenting these overexpressionbased immunofluorescence results. Indeed, when we tried to establish immunofluorescence of tagged Vps34 complexes (Vps34, Beclin1, or Atg14L) in MEFs, we realized that it was impractical to obtain expression of all subunits at the same levels as the endogenous proteins. There is indirect evidence showing different localization of Atg14L and UVRAG and, moreover, a partial overlap of Vps34 with either Atg14L or UVRAG (Itakura et al., 2008) .
In this study, we demonstrate that AMPK is necessary and sufficient for Vps34 regulation upon glucose starvation. Previously, we and others have shown AMPK in ULK1 regulation (Egan et al., 2011; Kim et al., 2011) . Although lines of evidence indicate ULK1 acting upstream of Vps34 (Di Bartolomeo et al., 2010; Itakura and Mizushima, 2010) , it is unclear how ULK1 regulates Vps34. Some reports show that ULK1 is dispensable for autophagy, possibly explained by redundancy with ULK2 (Cheong et al., 2011; Egan et al., 2011) . The lack of constitutively active ULK1 or Vps34 hampers us to reach a definitive conclusion. Interestingly, we observed that long-term glucose starvation could activate ULK1-independent autophagy (Figure S7H) , whereas ULK1 is required for the short-term starvation ( Figure S7I ). In contrast, the Vps34 complex is necessary for both short-and long-term starvation, revealing the complexity of autophagy regulation.
In conclusion, this study reveals a molecular mechanism for the differential regulation of different Vps34 complexes under energy starvation ( Figure 7F ), in which AMPK inhibits the nonautophagy Vps34 complexes by phosphorylating Vps34 and activates proautophagy Vps34 complexes by phosphorylating Beclin1. The presence of the autophagy factor Atg14L inhibits Vps34 phosphorylation and promotes Beclin1 phosphorylation, thereby converting the AMPK-mediated inhibition of Vps34 to activation.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
Anti-phospho-Beclin1 S91/S94 and Vps34 T163/S165 antibodies were generated by immunizing rabbits with the corresponding phosphopeptides, and the phosphospecific antibodies were affinity purified (Cell Signaling Technology). The details on other antibodies and the reagents can be found in the Extended Experimental Procedures.
Cell Death and PI(3)P-ELISA Assays Cell viability was determined by trypan blue staining and the apoptotic cells were examined by Annexin V/propidium iodide (PI) staining. The total amount of PI(3)P was measured by a quantitative ELISA assay (Echelon Biosciences). See the Extended Experimental Procedures for details.
AMPK Kinase Assay
Bacterial-purified GST-Beclin1 or GST-Vps34 proteins were used as substrates for AMPK in vitro phosphorylation. See the Extended Experimental Procedures for details.
Immunofluorescence Staining and Image Quantification LC3 puncta and total cellular PI(3)P were stained by anti-LC3 antibody (Cell Signaling Technology) and biotinylated-GST-2xFYVE proteins, respectively. Staining images were analyzed on a Zeiss LSM confocal microscope. See the Extended Experimental Procedures for details on immunostaining steps and image quantification.
Electron Microscopy MEF cells were starved for glucose for 3 hr, fixed in a modified Karnovsky's fixative (1.5% glutaraldehyde, 3% paraformaldehyde, and 5% sucrose in 0.1 M cacodylate buffer [pH 7.4]), and then stained with uranyl acetate and lead nitrate. The details on electron microscopy analysis are shown in the Extended Experimental Procedures.
In Vitro Vps34 Lipid Kinase Assay Vps34 immune complexes were incubated in a buffer (20 mM HEPES, 1 mM EGTA, 0.4 mM EDTA, 5 mM MgCl 2 , 0.05 mM DTT, 50 mM ATP, 5 mM MnCl 2 , and 50 mM DTT [pH 7.4]) containing 0.1 mg/ml PI and 5 mCi 32 P-ATP at 37 C for 30 min. Reactions were terminated by adding 1/5 vol of 1N HCl, and the lipid was extracted by 2 vol of CHCl 3 :MeOH (1:1 
